Pfizer’s sasanlimab combo significantly improves event-free survival in BCG-naïve, high-risk non-muscle invasive bladder cancer: New York Tuesday, April 29, 2025, 14:00 Hrs [IS ...

From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals ...

Pfizer Inc. today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus ...

Simultaneously, Reuters reported that the Nasdaq Composite is also undergoing a correction ... and launching innovations like its prefilled syringe for self-administration. The company’s robust ...

The case itself is made up of titanium with carbon composite flanks (made up of 60 ... everything about this piece screams yes to me. I love the syringe hands. The strap options.

Pfizer’s sasanlimab, combined with BCG therapy, significantly improved event-free survival in patients with BCG-naïve, ...

From the syringe hands to the strap options ... The case itself is made up of titanium with carbon composite flanks (made up of 60 per cent Nylo and 40 per cent carbon fibre) and while you may assume ...

This is an important study utilizing innovative CRISPR based approaches demonstrating the role of the KLF family of transcription factors in the post natal maturation of cortical projection neurons.

All three of the major stock market averages are holding onto gains, led by a 2.4% pop in the Nasdaq Composite. Mag Seven stocks are continuing to power the Nasdaq Composite higher, including ...

The Composite PMI climbed to 60.0, signaling the strongest growth since August, with manufacturing hitting a one-year high. New export orders soared, boosting output and employment across both ...